id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
aiua-9892	Jarimba, Roberto Saldanha; Eliseu, Miguel Nobre ; Pedroso Lima, João; Quaresma, Vasco ; Moreira, Pedro ; Coelho Nunes, Pedro; Tavares da Silva, Edgar ; Figueiredo, Arnaldo José 	Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective study	2021	6	.pdf	application/pdf	3858	192	47	Since 1941, when Charles Huggins and colleagues uncov- ered the hormonal dependence of metastatic prostate cancer, androgen deprivation therapy has been the thera- peutical mainstay for metastatic prostate cancer. Abiraterone and enza- lutamide were the first two novel hormonal agents approved for the treatment of metastatic prostate cancer but there is a lack of quality evidence regarding which is associated with better outcomes and who would benefit the most with one or another of these drugs.	cache/aiua-9892.pdf	txt/aiua-9892.txt